Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Stocks Crossing The 13 Week Moving Average <$10.01 -- Ignore unavailable to you. Want to Upgrade?

To: James Strauss who wrote (5355)	11/8/1999 9:59:00 PM
From: Jibacoa	Read Replies (1) \| Respond to of 13094

Jim: CPSS: Good up % move on Friday, but has formed a temporary double top at 1 3/4. It seems it is going to test the 1 1/4 40 1 3/8 area. I would buy on a stop at 1 7/16 to watch closely wether it can go above 1 3/4 Bernard

To: James Strauss who wrote (5355)	11/8/1999 10:10:00 PM
From: Jibacoa	Read Replies (1) \| Respond to of 13094

JIM: INDI: It slowed somewhat the up-trend momentum it has since November 1, apparently while testing the October 4 H. It may go to test the September 13 H at 4.468 The Feb 99 H was 11.873 and the May 96 H 14. Bernard

To: James Strauss who wrote (5355)	11/8/1999 10:20:00 PM
From: Jibacoa	Read Replies (1) \| Respond to of 13094

JIM: CDO: The price is out of the range for this thread (It closed at 21 1/2). It started the day on the down side (low was 19 3/8) in spite of today's favorable article on Fortune Magazine. It seems to have resistance at the 22 1/2 to 24 area. I have bought it on dips because of the potential of PRISM and the portfolio of companies it carries on its Venture Capital division (etoys among them) which according to Fortune's article it has been estimated to have a value around $1 billion. Bernard

To: James Strauss who wrote (5355)	11/8/1999 11:03:00 PM
From: Jibacoa	Read Replies (1) \| Respond to of 13094

JIM: BNRX: Friday's H at 3 1/8 was above the Oct.7 H at 2 1/2. Today the stock was down 12 % closing at 2 1/16, near the L of 2. It seems it may re-test the 1.875 The Jul.99 H was 5 1/4 and the Apr.97 H 14.625. The company's Lipogenics Division is doing some research on Vitamin E derivatives. As you know Vitamin's use has increased substantially in the past few years and there is a good amount of evidence in favor of its benefit as "anti-occidant", especially preventing the oxidation of LDH, which is probably one of the factors that triggers the intra-arterial deposition of cholesterol. Their more recent news concerning Niacin, doesn't seem significant. There is no question of the value of Niacin as agent for hypercholesterolemia, and we have some slow release preparations of Niacin that seem to minimize the "flushing" sensation, which has been one of the major side effects. The problem with some of those old drugs is that they are not patentable. Searle has just found that Aldactone has better results in treating CHF than the ACE inhibitors or the newer Ace receptor inhibitors, as reported in an article on the WSJ and the NEMJ last week, but they are going to wait for a new derivative they are now researching instead of promoting Aldactone itself, since the drug's patent expired several years ago. Bernard